Cyramza 500 mg/50 mL (10 mg/mL) injection Images
Generic Name: ramucirumab
This medication has been identified as Cyramza 500 mg/50 mL (10 mg/mL) injection. It is supplied by Eli Lilly and Company.
Cyramza is used in the treatment of Stomach Cancer; Gastric Cancer; Non Small Cell Lung Cancer; Colorectal Cancer; Hepatocellular Carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Cyramza 500 mg/50 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Cyramza
- Generic Name
- ramucirumab
- Strength
- 500 mg/50 mL (10 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- VEGF/VEGFR inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-7678
More about Cyramza (ramucirumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.